Primidone

From Anvita Health Wiki

Jump to: navigation, search

Contents

Introduction

  • Tradename: Primaclone, Mysoline.

Indications

Dosage

  • day 1-3: 100-125 mg QHS
  • day 4-6: 100-125 mg BID
  • day 7-9: 100-125 mg TID
  • day 10: maintenance dose
  • Tabs: 50 & 250 mg
  • Liquid: 250 mg/5 mL .

Pharmacokinetics

  • approximately 40% of drug excreted unchanged into urine
  • elimination 1/2life

Monitor

Adverse-effects

  • common (> 10%)
  • less common (1-10%)
  • uncommon (< 1%)

Drug-interactions

Laboratory

  • specimen:

Mechanism-of-action

More General Terms

Additional Terms

Internet Database

PubChem: 4909
PubChem: 589869

References

  1. The Pharmacological Basis of Therapeutics, 9th ed. Gilman et al, eds. Permagon Press/McGraw Hill, 1996
  2. Harrison's Principles of Internal Medicine, 13th ed. Companion Handbook. Isselbacher et al (eds), McGraw-Hill Inc. NY, 1995, pg 700.
  3. The Pharmacological Basis of Therapeutics, 8th ed. Gilman et al, eds. Permagon Press/McGraw Hill pg 446
  4. Drug Information & Medication Formulary, Veterans Affairs, Central California Health Care System, 1st ed., Ravnan et al eds, 1998
  5. Kaiser Permanente Northern California Regional Drug Formulary, 1998
  6. Clinical Guide to Laboratory Tests, NW Tietz (ed) 3rd ed, WB Saunders, Philadelpha 1995
  7. Prescriber's Letter 13(3): 2006 Cytochrome P450 drug interactions Detail-Document#: [1] (subscription needed) [2]
  8. Anvita Health guideline :id 1686

Personal tools